Thomas Plitz
Vorstandsvorsitzender bei Chord Therapeutics SA
Vermögen: 1 690 $ am 30.04.2024
Profil
Thomas Plitz is currently the Chief Executive Officer at Chord Therapeutics SA and the Vice Chairman at RELIEF THERAPEUTICS Holding SA. Previously, he held positions as Principal at Shire Pharmaceuticals, Inc., Serono Corp., and Merck Serono Ltd.
He also served as the Chief Scientific Officer at Wilson Therapeutics AB.
Dr. Plitz obtained a doctorate degree from Technische Universität München.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.04.2023 | 1 250 ( 0,01% ) | 1 690 $ | 30.04.2024 |
Aktive Positionen von Thomas Plitz
| Unternehmen | Position | Beginn |
|---|---|---|
Chord Therapeutics SA
 Chord Therapeutics SA BiotechnologyHealth Technology Chord Therapeutics SA is a clinical stage pharmaceutical company. It develops drugs for patients with rare, life-threatening and severely disabling diseases. The firm offers CRD1. The company was founded by Arthur Roach and is headquartered in Geneva, Switzerland. | Vorstandsvorsitzender | 01.08.2020 |
Ehemalige bekannte Positionen von Thomas Plitz
| Unternehmen | Position | Ende |
|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Direktor/Vorstandsmitglied | 26.04.2024 |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | - |
| Serono Corp. | Corporate Officer/Principal | - |
| WILSON THERAPEUTICS AB | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Thomas Plitz
| Technische Universität München | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
| Serono Corp. | |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Commercial Services |
Chord Therapeutics SA
Chord Therapeutics SA BiotechnologyHealth Technology Chord Therapeutics SA is a clinical stage pharmaceutical company. It develops drugs for patients with rare, life-threatening and severely disabling diseases. The firm offers CRD1. The company was founded by Arthur Roach and is headquartered in Geneva, Switzerland. | Health Technology |
